Abstract

The human epidermal growth factor receptor 2 (HER2) gene amplification status is a crucial marker for evaluating clinical therapies of breast or gastric cancer. We propose a deep learning-based pipeline for the detection, localization and classification of interphase nuclei depending on their HER2 gene amplification state in Fluorescence in situ hybridization (FISH) images. Our pipeline combines two RetinaNet-based object localization networks which are trained (1) to detect and classify interphase nuclei into distinct classes normal, low-grade and high-grade and (2) to detect and classify FISH signals into distinct classes HER2 or centromere of chromosome 17 (CEN17). By independently classifying each nucleus twice, the two-step pipeline provides both robustness and interpretability for the automated detection of the HER2 amplification status. The accuracy of our deep learning-based pipeline is on par with that of three pathologists and a set of 57 validation images containing several hundreds of nuclei are accurately classified. The automatic pipeline is a first step towards assisting pathologists in evaluating the HER2 status of tumors using FISH images, for analyzing FISH images in retrospective studies, and for optimizing the documentation of each tumor sample by automatically annotating and reporting of the HER2 gene amplification specificities.

Details

Title
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues
Author
Zakrzewski Falk 1 ; de Back Walter 2   VIAFID ORCID Logo  ; Weigert, Martin 3 ; Wenke Torsten 4 ; Zeugner Silke 5 ; Mantey, Robert 6 ; Sperling, Christian 5 ; Friedrich Katrin 5 ; Roeder Ingo 7   VIAFID ORCID Logo  ; Aust, Daniela 8 ; Baretton Gustavo 8 ; Hönscheid Pia 8 

 University Hospital Carl Gustav Carus (UKD), TU Dresden, Institute of Pathology, Dresden, Germany 
 Carl Gustav Carus Faculty of Medicine, TU Dresden, Institute for Medical Informatics and Biometry (IMB), Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257); TU Dresden, Center for Information Services and High Performance Computing (ZIH), Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257) 
 Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany (GRID:grid.419537.d) (ISNI:0000 0001 2113 4567); Center for Systems Biology Dresden (CSBD), Dresden, Germany (GRID:grid.495510.c) 
 ASGEN GmbH & Co. KG, Dresden, Germany (GRID:grid.495510.c) 
 University Hospital Carl Gustav Carus (UKD), TU Dresden, Institute of Pathology, Dresden, Germany (GRID:grid.495510.c) 
 Partner Site Dresden, National Center for Tumor Diseases (NCT), Dresden, Germany (GRID:grid.495510.c) 
 Carl Gustav Carus Faculty of Medicine, TU Dresden, Institute for Medical Informatics and Biometry (IMB), Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257); Partner Site Dresden, National Center for Tumor Diseases (NCT), Dresden, Germany (GRID:grid.4488.0) 
 University Hospital Carl Gustav Carus (UKD), TU Dresden, Institute of Pathology, Dresden, Germany (GRID:grid.4488.0); Partner Site Dresden, National Center for Tumor Diseases (NCT), Dresden, Germany (GRID:grid.4488.0) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2233818586
Copyright
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.